Where Chemours Stands With Analysts
Portfolio Pulse from Benzinga Insights
Chemours (NYSE:CC) has received various analyst ratings in the last quarter, with 1 bullish, 2 somewhat bullish, 5 indifferent, and 1 somewhat bearish. The average price target from these 9 analysts is $40.67, which is higher than the current price of $37.765. This average has increased by 1.96% from the previous average price target of $39.89.
July 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Chemours has received mixed analyst ratings, with an average price target of $40.67, indicating potential upside from the current price.
The average price target from analysts is higher than the current price of Chemours, indicating potential upside. However, the ratings are mixed, with some analysts being bullish and others indifferent or somewhat bearish. This could lead to volatility in the short term, but the overall trend suggests a potential increase in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100